Literature DB >> 9066931

Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.

G D Anderson1, C Pak, K W Doane, K G Griffy, N R Temkin, A J Wilensky, H R Winn.   

Abstract

OBJECTIVE: To develop a revised equation reflecting the current practice of measuring unbound phenytoin at room temperature, and to evaluate the revised Winter-Tozer method of predicting normalized total phenytoin concentrations in two groups of patients with hypoalbuminemia-elderly nursing home patients and critically ill head trauma patients.
DESIGN: Albumin, unbound phenytoin, and total phenytoin concentrations were obtained from two sources: prospectively from a group of elderly nursing home patients and by a retrospective chart review of trauma patients enrolled in a previous double-blind, placebo-controlled study.
SETTING: Community nursing homes; a university-affiliated urban teaching hospital. PARTICIPANTS: Elderly nursing home patients (n = 46) taking chronic phenytoin therapy and patients enrolled in a double-blind, placebo-controlled study (n = 58) evaluating the use of phenytoin to prevent posttraumatic seizures. MAIN OUTCOME MEASURES: Prediction error analysis was performed by using the methods proposed by Sheiner and Beal. Bias and precision were evaluated by calculating the mean prediction error (MPE) and root mean squared error (RMSE), respectively.
RESULTS: The Winter-Tozer equation consistently overpredicted the normalized phenytoin concentration in the elderly nursing home population (MPE = 3.2, RMSE = 5.9) and the trauma patients (MPE = 3.3, RMSE = 4.8). The equation was revised to reflect the increased protein binding of phenytoin with decreased temperature and resulted in significantly decreased bias in both groups of patients.
CONCLUSIONS: The revised equation is useful in predicting normalized phenytoin concentrations in both elderly nursing home patients and critically ill trauma patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066931     DOI: 10.1177/106002809703100301

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  16 in total

1.  Calculation of normalized drug concentrations in the presence of altered plasma protein binding.

Authors:  Florin Marcel Musteata
Journal:  Clin Pharmacokinet       Date:  2012-01-01       Impact factor: 6.447

Review 2.  Management of newly diagnosed epilepsy: a practical guide to monotherapy.

Authors:  Michael A Stein; Andres M Kanner
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.

Authors:  Gail D Anderson; Shahin Hakimian
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

4.  Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Authors:  Kim Vanstraelen; Joost Wauters; Ine Vercammen; Henriette de Loor; Johan Maertens; Katrien Lagrou; Pieter Annaert; Isabel Spriet
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

Review 5.  Treating epilepsy in the elderly: safety considerations.

Authors:  S Arroyo; G Kramer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury.

Authors:  G D Anderson; A B Awan; C A Adams; N R Temkin; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

7.  Predictive Performance of the Winter-Tozer and Derivative Equations for Estimating Free Phenytoin Concentration.

Authors:  Wendy Cheng; Tony K L Kiang; Penny Bring; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2016-08-31

8.  Retrospective analysis of levetiracetam compared to phenytoin for seizure prophylaxis in adults with traumatic brain injury.

Authors:  G Christina Caballero; Darrel W Hughes; Pamela R Maxwell; Kay Green; Conrado D Gamboa; Colleen A Barthol
Journal:  Hosp Pharm       Date:  2013-10

9.  Pharmacokinetic Factors to Consider in the Selection of Antiseizure Drugs for Older Patients with Epilepsy.

Authors:  Gail D Anderson; Shahin Hakimian
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

10.  Method for Simultaneous Determination of Free Concentration, Total Concentration, and Plasma Binding Capacity in Clinical Samples.

Authors:  Dorina Cibotaru; Marie N Celestin; Michael P Kane; Florin M Musteata
Journal:  J Pharm Sci       Date:  2020-12-08       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.